Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation
iMetaOmics · 2025-12 · 2 (4)
DOI: 10.1002/imo2.70065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift iMetaOmics, online erschienen am 24.11.2025. Verfasst von Yue Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Medicine and Biotherapy, the Ministry of Industry and Information Technology, School of Life Science Beijing Institute of…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The theoretical framework of the microbiota‐gut‐brain axis (MGBA) elucidates the influence of gut microbiota (GM) on the central nervous system (CNS) and offers novel approaches for diagnosing and treating neurological disorders. The application of microfluidic organ chips to study this axis represents an innovative methodology, enabling multidisciplinary assessment of drug effects. Bionic microphysiological systems based on these chips establish a groundbreaking paradigm for analyzing cross‐organ interaction mechanisms within the MGBA. This technology facilitates systematic evaluation of pharmacokinetics, host‐microbe coevolution, and neuroendocrine regulation, thereby supporting multimodal cross‐validation in pharmacodynamics, toxicology, and translational medicine. This review summarizes the conceptual foundation and mechanistic insights of the MGBA, highlights recent advances in its constituent Multiorgan components, including gut‐on‐a‐chip, blood‐brain barrier‐on‐a‐chip, and brain‐on‐a‐chip models, alongside multiorgan chip cascade technologies, and underscores their applications in drug evaluation. Additionally, it discusses future challenges and developmental directions for the MGBA multiorgan chip technologies in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Molecular Medicine and Biotherapy, the Ministry of Industry and Information Technology, School of Life Science Beijing Institute of Technology Beijing China.
- Advanced Technology Research Institute Beijing Institute of Technology Jinan China.
- Institute of Environmental Biology and Life Support Technology, School of Biological Science and Medical Engineering Beihang University Beijing China.
- Shandong Institute for Food and Drug Control Jinan China.
- Department of Statistics the George Washington University Washington District of Columbia USA.
ORCID-Profile: Axin Liang, Aiqin Luo
Zitieren
APA
Tang, Y., Chen, H., Zhao, Z., Kang, X., Wang, W., Dai, K., Guo, Y., Liang, A., Luo, A., & Hao, Z. (2025). Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation. iMetaOmics, 2(4). https://doi.org/10.1002/imo2.70065
Vancouver
Tang Y, Chen H, Zhao Z, Kang X, Wang W, Dai K, et al. Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation. iMetaOmics. 2025;2(4). doi:10.1002/imo2.70065
BibTeX
@article{Tang2025,
author = {Tang, Yue and Chen, Hewen and Zhao, Ziyue and Kang, Xuesong and Wang, Wenxin and Dai, Kun and Guo, Yufei and Liang, Axin and Luo, Aiqin and Hao, Zikai},
title = {Microbiota‐gut‐brain axis multi‐organ chip construction and applications in drug evaluation},
journal = {iMetaOmics},
year = {2025},
volume = {2},
number = {4},
doi = {10.1002/imo2.70065}
}
EUVIMED